Published in Diabetologia on January 01, 1999
Epidemiology of sudden cardiac death: clinical and research implications. Prog Cardiovasc Dis (2008) 4.09
Determinants of prolonged QT interval and their contribution to sudden death risk in coronary artery disease: the Oregon Sudden Unexpected Death Study. Circulation (2009) 2.31
Autonomic neuropathy and QT interval in hemodialysed patients. Clin Auton Res (2004) 1.48
Cardiovascular autonomic neuropathies as complications of diabetes mellitus. Nat Rev Endocrinol (2012) 1.36
Cardiac autonomic neuropathy in patients with diabetes mellitus. World J Diabetes (2014) 1.19
Diabetes and cardiac autonomic neuropathy: Clinical manifestations, cardiovascular consequences, diagnosis and treatment. World J Diabetes (2015) 1.08
Increased QT interval dispersion predicts 15-year cardiovascular mortality in type 2 diabetic subjects: the population-based Casale Monferrato Study. Diabetes Care (2012) 0.92
Increased persistent sodium current due to decreased PI3K signaling contributes to QT prolongation in the diabetic heart. Diabetes (2013) 0.91
Control of cardiac repolarization by phosphoinositide 3-kinase signaling to ion channels. Circ Res (2015) 0.88
Prevalence and risk factors of prolonged QTc interval among Chinese patients with type 2 diabetes. Exp Diabetes Res (2012) 0.88
Long QTc predicts future cardiac death in stroke survivors. Heart (2003) 0.87
Plasma leptin level is associated with cardiac autonomic dysfunction in patients with type 2 diabetes: HSCAA study. Cardiovasc Diabetol (2015) 0.82
Utility of nonspecific resting electrocardiographic features for detection of coronary artery stenosis by computed tomography in acute chest pain patients: from the ROMICAT trial. Int J Cardiovasc Imaging (2011) 0.78
Electrophysiological mechanisms of long and short QT syndromes. Int J Cardiol Heart Vasc (2016) 0.75
The effect of 25-hydroxyvitamin D levels on QT interval duration and dispersion in type 2 diabetic patients. Croat Med J (2015) 0.75
Multiple logistic regression analysis of risk factors in elderly pneumonia patients: QTc interval prolongation as a prognostic factor. Multidiscip Respir Med (2014) 0.75
The influence of type 2 diabetes and gender on ventricular repolarization dispersion in patients with sub-clinic left ventricular diastolic dysfunction. Am J Cardiovasc Dis (2015) 0.75
Sudden cardiac death in low- and middle-income countries. Glob Heart (2012) 0.75
Cardiovascular Action of Insulin in Health and Disease: Endothelial L-Arginine Transport and Cardiac Voltage-Dependent Potassium Channels. Front Physiol (2016) 0.75
Prevalence of QT prolongation and associated LVEF changes in diabetic patients over a four-year retrospective time period. J Community Hosp Intern Med Perspect (2017) 0.75
Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study. Lancet (1980) 4.86
Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia (2001) 4.22
Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study. Br Med J (Clin Res Ed) (1983) 3.28
Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/beta -catenin signaling is activated in human colon tumors. Proc Natl Acad Sci U S A (2001) 2.77
Diabetes mortality: new light on an underestimated public health problem. Diabetologia (1983) 2.37
Early closure of European Pimagedine trial. Steering Committee. Safety Committee. Lancet (1997) 2.28
The value of the post-take ward round: are new working patterns compromising junior doctor education? Clin Med (2009) 2.20
Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes--the EURODIAB Prospective Complications Study. Diabetologia (2005) 2.16
Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia (1996) 2.15
Cardiovascular disease and its risk factors in IDDM in Europe. EURODIAB IDDM Complications Study Group. Diabetes Care (1996) 2.11
Long-term adaptive changes in primate vestibuloocular reflex. III. Electrophysiological observations in flocculus of normal monkeys. J Neurophysiol (1980) 1.96
Haemostatic variables associated with diabetes and its complications. Br Med J (1979) 1.90
Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus. Diabetologia (2004) 1.73
Mortality and morbidity from diabetes in South Asians and Europeans: 11-year follow-up of the Southall Diabetes Survey, London, UK. Diabet Med (1998) 1.72
ANTI-HSP60 and ANTI-HSP70 antibody levels and micro/ macrovascular complications in type 1 diabetes: the EURODIAB Study. J Intern Med (2009) 1.68
Social deprivation and mortality in adults with diabetes mellitus. Diabet Med (1998) 1.64
Worsening to diabetes in men with impaired glucose tolerance ("borderline diabetes"). Diabetologia (1979) 1.61
Parental history of hypertension and parental history of diabetes and microvascular complications in insulin-dependent diabetes mellitus: the EURODIAB IDDM Complications Study. Diabet Med (1998) 1.61
Determination of antidromic excitation by the collision test: problems of interpretation. Brain Res (1976) 1.58
Risk factors for cardiovascular mortality and morbidity: the WHO Mutinational Study of Vascular Disease in Diabetes. Diabetologia (2001) 1.56
All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992-1999. Diabetologia (2006) 1.47
Education and employment for young people with diabetes. Diabet Med (1993) 1.47
Exposure to candesartan during the first trimester of pregnancy in type 1 diabetes: experience from the placebo-controlled DIabetic REtinopathy Candesartan Trials. Diabetologia (2011) 1.46
Does abnormal QT interval prolongation reflect autonomic dysfunction in diabetic patients? QTc interval measure versus standardized tests in diabetic autonomic neuropathy. Diabet Med (1995) 1.43
Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes. Diabetes Care (2001) 1.38
Adaptive plasticity in the vestibulo-ocular responses of the rhesus monkey. Brain Res (1974) 1.36
The relationship between socioeconomic status and diabetes control and complications in the EURODIAB IDDM Complications Study. Diabetes Care (1996) 1.36
Nutrient intake, adiposity, and diabetes. Br Med J (1979) 1.34
The effect of type 1 diabetes mellitus on the gender difference in coronary artery calcification. J Am Coll Cardiol (2000) 1.34
Risk factors, ethnic differences and mortality associated with lower-extremity gangrene and amputation in diabetes. The WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia (2001) 1.33
The role of circulating glucose and triglyceride concentrations and their interactions with other "risk factors" as determinants of arterial disease in nine diabetic population samples from the WHO multinational study. Diabetes Care (1983) 1.32
Risk factors for progression to proliferative diabetic retinopathy in the EURODIAB Prospective Complications Study. Diabetologia (2001) 1.32
Microalbuminuria in type 1 diabetes: rates, risk factors and glycemic threshold. Kidney Int (2001) 1.26
Mortality risk by body weight and weight change in people with NIDDM. The WHO Multinational Study of Vascular Disease in Diabetes. Diabetes Care (1995) 1.26
Glucose tolerance and blood pressure in two population samples: their relation to diabetes mellitus and hypertension. Int J Epidemiol (1978) 1.25
Follow-up of the WHO Multinational Study of Vascular Disease in Diabetes: general description and morbidity. Diabetologia (2001) 1.24
Autonomic neuropathy is associated with increased cardiovascular risk factors: the EURODIAB IDDM Complications Study. Diabet Med (2002) 1.24
The relationship between smoking and microvascular complications in the EURODIAB IDDM Complications Study. Diabetes Care (1995) 1.23
Visual tracking and the primate flocculus. Science (1975) 1.23
Blood pressure, retinopathy and urinary albumin excretion in IDDM: the EURODIAB IDDM Complications Study. Diabetologia (1995) 1.22
Excess mortality and its relation to hypertension and proteinuria in diabetic patients. The world health organization multinational study of vascular disease in diabetes. Diabetes Care (1996) 1.20
Ethnic differences in mortality from cardiovascular disease in the UK: do they persist in people with diabetes? J Epidemiol Community Health (1996) 1.17
A prospective study of mortality among middle-aged diabetic patients (the London Cohort of the WHO Multinational Study of Vascular Disease in Diabetics) I: Causes and death rates. Diabetologia (1990) 1.13
Progression to microalbuminuria in type 1 diabetes: development and validation of a prediction rule. Diabetologia (2009) 1.11
Glycemic index in the diet of European outpatients with type 1 diabetes: relations to glycated hemoglobin and serum lipids. Am J Clin Nutr (2001) 1.10
Prevalence of increased QT interval duration and dispersion in type 2 diabetic patients and its relationship with coronary heart disease: a population-based cohort. J Intern Med (2002) 1.09
Which features of smoking determine mortality risk in former cigarette smokers with diabetes? The World Health Organization Multinational Study Group. Diabetes Care (1997) 1.07
Hyperglycaemia and coronary heart disease: the Whitehall study. J Chronic Dis (1979) 1.02
The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease. Atherosclerosis (2003) 1.01
Depression and diabetes. Diabet Med (1988) 1.01
Eye and head movements in the pigmented rat. Vision Res (1985) 1.01
Prevalence and risk factors for micro- and macroalbuminuria in an Italian population-based cohort of NIDDM subjects. Diabetes Care (1996) 1.00
The MCP-1/CCR2 system has direct proinflammatory effects in human mesangial cells. Kidney Int (2006) 0.96
Role of life events and difficulties in the onset of diabetes mellitus. J Psychosom Res (1985) 0.96
Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications Study. Diabetes Care (2001) 0.96
Plasma homocysteine and microvascular and macrovascular complications in type 1 diabetes: a cross-sectional nested case-control study. J Intern Med (2005) 0.95
The relationship of high density lipoprotein subfractions to alcohol consumption, other lifestyle factors, and coronary heart disease. Atherosclerosis (1988) 0.95
Cervicocollic reflex: its dynamic properties and interaction with vestibular reflexes. J Neurophysiol (1985) 0.95
The cytochrome subunit is necessary for covalent FAD attachment to the flavoprotein subunit of p-cresol methylhydroxylase. J Biol Chem (1995) 0.94
Proteinuria and mortality in diabetes: the WHO Multinational Study of Vascular Disease in Diabetes. Diabet Med (1995) 0.94
The association of heart-rate variability with cardiovascular risk factors and coronary artery calcification: a study in type 1 diabetic patients and the general population. Diabetes Care (2001) 0.94
International variations in mortality among diabetic patients: the WHO Multinational Study of Vascular Disease in Diabetics. Diabetologia (1990) 0.93
Validity of routinely collected hospital admissions data on diabetes. Diabet Med (1989) 0.93
A locus influencing total serum cholesterol on chromosome 19p: results from an autosomal genomic scan of serum lipid concentrations in Pima Indians. Arterioscler Thromb Vasc Biol (2000) 0.93
Rapid emergence of effect of atorvastatin on cardiovascular outcomes in the Collaborative Atorvastatin Diabetes Study (CARDS). Diabetologia (2005) 0.93
Carbohydrate sources and glycaemic control in Type 1 diabetes mellitus. EURODIAB IDDM Complications Study Group. Diabet Med (2000) 0.92
Possible seasonal variation of plasma lipids in a healthy population. Clin Chim Acta (1974) 0.92
Risk factors for macrovascular disease in diabetes mellitus: the London follow-up to the WHO Multinational Study of Vascular Disease in Diabetics. Diabetologia (1991) 0.92
Relationship between plasma sialic acid and fibrinogen concentration and incident micro- and macrovascular complications in type 1 diabetes. The EURODIAB Prospective Complications Study (PCS). Diabetologia (2008) 0.92
Incidence of macrovascular disease in diabetes mellitus: the London cohort of the WHO Multinational Study of Vascular Disease in Diabetics. Diabetologia (1991) 0.91
Antihypertensive therapy for preventing cardiovascular complications in people with diabetes mellitus. Cochrane Database Syst Rev (2000) 0.91
Weight gain is associated with improved glycaemic control but with adverse changes in plasma lipids and blood pressure isn Type 1 diabetes. Diabet Med (2006) 0.91
Association of physical activity with all-cause mortality and incident and prevalent cardiovascular disease among patients with type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetologia (2012) 0.90
Lipid transfer protein activities in type 1 diabetic patients without renal failure and nondiabetic control subjects and their association with coronary artery calcification. Diabetes (2001) 0.90
A prospective study of mortality among middle-aged diabetic patients (the London Cohort of the WHO Multinational Study of Vascular Disease in Diabetics) II: Associated risk factors. Diabetologia (1990) 0.90
Dietary saturated fat and fibre and risk of cardiovascular disease and all-cause mortality among type 1 diabetic patients: the EURODIAB Prospective Complications Study. Diabetologia (2012) 0.90
Risk factors for renal failure: the WHO Mulinational Study of Vascular Disease in Diabetes. Diabetologia (2001) 0.90
Design of the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with type 2 diabetes. Diabet Med (2002) 0.90
Differing associations of lipid and lipoprotein disturbances with the macrovascular and microvascular complications of type 1 diabetes. Diabetes Care (2001) 0.90
Relation of fibre intake to HbA1c and the prevalence of severe ketoacidosis and severe hypoglycaemia. EURODIAB IDDM Complications Study Group. Diabetologia (1998) 0.89
Alcohol consumption and risk of microvascular complications in type 1 diabetes patients: the EURODIAB Prospective Complications Study. Diabetologia (2008) 0.89
Prevalence of hypertension among diabetic patients and its relation to vascular risk. Diabetes Hypertension Study Group. J Hum Hypertens (1991) 0.88